Proxy Votes Now

Home › Funds › DWS › DWS Health and Wellness Fund

DWS Health and Wellness Fund (SCHLX) proxy voting record 2025-2026

Fund family: DWS · Filed by DEUTSCHE DWS SECURITIES TRUST (CIK 88048) · SEC series S000006103

Share classes and tickers: SCHLX (C000016786), SUHAX (C000016782), SUHCX (C000016785), SUHIX (C000016787)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 749 with, 22 against, 0 abstentions (not counted as with management). Shareholder proposals: 11 FOR, 11 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with DWS as a whole

The same two figures as DWS’s manager page (256,084 ballot items across 82 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsDWSItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)95.4%71191.4%200,577
Backed environmental and social shareholder proposals at US companiesn/a631.1%2,251

Where this fund voted differently from most DWS funds

Each ballot item this fund voted is set against the votes of the other DWS funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most DWS funds on all 672 items where a comparison was possible.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 81.6% of this fund’s 771 such votes could be given a sector; the other 142 (18.4%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care559223.9%
Industrials6000.0%
Technology1000.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections5220
Audit-related580
Say-on-Pay560
Compensation491
Corporate Governance4815
Capital Structure280
Other Social Issues43
Shareholder Rights and Defenses40
Environment or Climate33
Extraordinary Transactions10

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Eli Lilly and CompanyMay 4, 2026$46M102
Johnson & JohnsonApril 23, 2026$18M151
UnitedHealth Group IncorporatedJune 1, 2026$17M121
AbbVie Inc.May 8, 2026$15M81
Merck & Co., Inc.May 26, 2026$14M183
Thermo Fisher Scientific Inc.May 20, 2026$11M130
Amgen Inc.May 19, 2026$9M151
McKesson CorporationJuly 30, 2025$9M140

Notable votes against management

MeetingCompanyProposalFundMgmt
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalForAgainst
May 4, 2026Eli Lilly and CompanyShareholder proposal to prepare an annual lobbying report. Shareholder proposalForAgainst
April 23, 2026Johnson & JohnsonIndependent Board Chair Shareholder proposalAgainstFor
June 1, 2026UnitedHealth Group IncorporatedIf properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposalAgainstFor
May 8, 2026AbbVie Inc.Stockholder Proposal - to Adopt a Policy to Require an Independent Chair Shareholder proposalForAgainst
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalAgainstFor
May 19, 2026Amgen Inc.Stockholder proposal to require an independent board chairman. Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposalForAgainst
May 13, 2026Vertex Pharmaceuticals IncorporatedShareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposalForAgainst
April 30, 2026Boston Scientific CorporationStockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting." Shareholder proposalForAgainst

Search this fund’s votes by company

773 ballot items at 62 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, DWS Health and Wellness Fund (SCHLX) voted at 62 shareholder meetings of 60 companies, on 773 ballot items in all. Where management made a recommendation, the fund followed it on 97.1% of the items and voted against it 22 times. Its most frequent area of disagreement was corporate governance (15 of its votes against management). It voted on 22 shareholder proposals. It voted FOR the board's own proposals more often than DWS's funds as a whole (95.4% against 91.4%). It voted the same way as most DWS funds on every item where a comparison was possible.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of DWS’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.